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578a Wednesday, February 11, 2015the protein-lipid interface to drive activation of the voltage-sensors. This
motif is an important pharmacological target for amphipathic neurotoxins
and it has been suggested that it is conserved in other voltage-gated ion
channels. Here we show that the four S3b-S4 paddle motifs within the
T-type calcium channel could be transplanted into four-fold symmetric Kv
channel to individually examine their contributions to the kinetics of voltage
sensor activation and pharmacology. Using these chimeric constructs,
we screened existing gating-modifier toxins against the putative paddle
motif from each domain of T-type calcium channel, Cav3.1. We found
that the four individual paddle motifs of Cav3.1 channels display unique
toxin binding capabilities, suggesting that gating-modifier toxins can bind
to T-type calcium channels in a domain-specific fashion. Comparing
ProTx-II-like toxins effect on T-type calcium channels and chimeras
suggests potential amino acids involved in the direct interaction between
toxin and channels.
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High-voltage activated calcium channels (CaV1.1–CaV1.4; CaV2.1–CaV2.3)
link electrical signals to vital physiological responses in excitable cells.
Molecules that block CaV1/CaV2 channels are important therapeutics. Rad/
Rem/Rem2/Gem (RGK) proteins are small Ras-like G-proteins that potently
and indiscriminately inhibit all CaV1/CaV2 channels. The practical utility
of RGKs as genetically-encoded CaV channel blockers would be vastly
improved if it were possible to engineer versions that display selective inhi-
bition of distinct CaV1/CaV2 isoforms. CaV1/CaV2 pore-forming a1 subunits
require binding to auxiliary CaVbs to generate functional channels. All RGKs
bind wild-type (wt) CaVb and this interaction is disrupted in a mutated
CaVb (CaVbTM). We compared the ability of Rem and Gem to inhibit four
distinct CaV1s (CaV1.2, CaV1.3, CaV2.1 and CaV2.2) reconstituted with either
wtCaVb or CaVbTM in HEK293 cells. While both Rem and Gem blocked
all channels reconstituted with wtCaVb, Rem uniquely suppressed CaV1.2þ
b2aTM channels, a signature of CaVb-binding-independent inhibition. Using
FRET analyses, chimeric Rem/Gem proteins, and electrophysiology we
show that CaVb-binding-independent inhibition of CaV1.2 involves direct
interaction of Rem C-terminus with CaV1.2a1C N-terminus, and additionally
requires the Rem nucleotide-binding domain. A mutant Rem that no longer
interacts with CaVb (Remb-null) selectively inhibited CaV1.2þwtCaVb
channels. We further profiled the prevalence of b-binding-dependent
and -independent mechanisms of inhibition by Rem2 and Rad across CaV1/
CaV2 channel families. While Rem2 relied on CaVb binding to inhibit
all four CaVs tested, Rad displayed b-binding-independent inhibition of
CaV1.2 and CaV2.2. Consistent with this, Remb-null selectively inhibited
CaV1.2 and CaV2.2 channels reconstituted with wtCaVb. In summary, our
results have revealed a latent capability of distinct RGK proteins to block
particular CaV1/CaV2 channels in an a1-subunit-specific manner. We have
exploited this feature to generate genetically-encoded CaV-isoform-selective
inhibitors.
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Background: In a diabetic mouse model (db/db) we have shown reduced ICaL
density with unchanged single-channel activity and reduced expression of the
LTCC pore Cav1.2 (Pereira et al., Diabetes 2006;55:608-15). Of note, LTCC
expression and function can be decreased by RGK proteins, including the
diabetes-associated protein Rad. Aim of the study: In the present study, we
investigate the association between cardiac Rad expression with the expression
and function of ventricular LTCC in two mouse models with diabetes-related
metabolic disturbances (leptin-deficient obese ob/ob mice and insulin receptor
substrate 2 deficient IRS2-k.o. mice).Methods:We obtained expression of Rad
and Cav1.2 protein (Western-blot) and mRNA (qRT-PCR) in murine ventricles
and recorded whole-cell ICaL in freshly isolated ventricular myocytes. Results:
The only significant change at the mRNA level was an increased Rad expres-
sion in IRS2-k.o. mice at 16 weeks of age (206517%). In line with this finding
ICaL density was significantly decreased (IRS2-k.o.: 7.850.8 pA/pF; wild-
type: 10.950.9 pA/pF). At an age of 28 weeks, we found expression of
both Rad and Cav1.2 protein to be significantly increased in ventricles from
ob/ob mice compared to age-matched widtypes (273523% and 159514%,
respectively) while ICaL density was unchanged (ob/ob: 8.450.4 pA/pF;wildtype: 8.950.5 pA/pF). Summary and discussion: Our data support
the idea of Rad being involved in regulation of ICaL in diabetes. Regarding
ICaL Rad seems to act either causal (ICaL decrease in IRS2-k.o. at 16 weeks)
or compensatory (increased Cav1.2 expression but unchanged ICaL in ob/ob
at 28 weeks). Differences observed between the two investigated diabetic
mouse models might be explained by differences in the underlying pathome-
chanisms (lack of IRS2 vs. leptin deficiency, respectively).
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Neuronal voltage-gated Cav2.3 channels are widely expressed in the central and
peripheral nervous system where they contribute to neurotransmission and pain
sensation. However, modulation of the Cav2.3 channel through G protein-
coupled (GPC) m- and d-opioid receptors is poorly defined and has not previ-
ously been reported for k-opioid receptors. We hypothesized that activation
of human m-, d- or k-opioid receptors modulates Cav2.3 channels via G protein
signaling. Whole-cell Ba2þ currents were recorded in HEK293T cells co-
expressing human Cav2.2 or Cav2.3 channels and m-, d- or k-opioid receptors.
Selective opioid receptor agonists and antagonists were used to study receptor
modulation. The involvement of intracellular signaling pathways was investi-
gated using specific inhibitors of GPC receptor-G protein coupling. Activation
of m-, d- or k-opioid receptors inhibited Cav2.3 and Cav2.2 channel current
amplitude by ~45% and ~60%, respectively. Inhibition of Cav2.3 was not
dependent on the type of subunit co-expressed. Inhibition of the Cav2.3 channel
was primarily voltage independent, as depolarizing prepulses could not relieve
the inhibited current. This was in marked contrast with the primarily voltage-
dependent modulation of Cav2.2 channels that showed nearly complete recov-
ery of the inhibited current with depolarizing prepulses. For all three types of
opioid receptors, the pathway leading to Cav2.3 channel inhibition was sensi-
tive to pertussis toxin and intracellular application of GDP-b-S. Similarly,
the overexpression of a G protein subunit scavenger, myristoylated-
phosducin, significantly reduced the magnitude of Cav2.3 channel inhibition.
Here we demonstrate that Cav2.3 channels are efficiently inhibited by activa-
tion of m-, d- or k-opioid receptors. Inhibition occurs via voltage-independent
G protein signaling mechanisms. These results suggest opioid receptor controls
specific members of the Cav2 channel family via differential signaling
pathways. Neuronal Cav2.3 channels are therefore potential targets for opioid
analgesics.
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g6 subunit of voltage-gated calcium channels is expressed in the heart and
in the brain. It modulates gating of T-type channels (Hansen et al., 2004;
Lin et al., 2008). It also associates with CaV1.2 channels and enhances their
inactivation in the presence of the b1b, but not b2b, subunit (Yang et al., 2010).
We found that g6 subunit dramatically reduces the number of functional a1/
b2a channels expressed in tsA-201 cells. Channels with the g6 are trapped in
the Golgi complex. Deletions of N-termini of a1 and g6 subunits restore func-
tional targeting to the plasma membrane.
We propose that the g6 regulates functional expression of CaV1.2 channels by
interacting with the pore-forming a1 subunit or with another protein in the
complex.
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Low voltage activated T-type calcium channels (TTCC) play a pivotal role in
the developing heart. Although the TTCC isoforms, Cav3.1 and Cav3.2, under-
lie cardiac TTCC current (ICa,T) and are expressed in atrial and ventricular
myocytes during development, their expression and roles recede in the adult
heart. However, previous studies have demonstrated the re-expression of
ICa,T in pathological cardiac hypertrophy, suggesting that TTCCs contribute
to the altered Ca2þ cycling and signaling in these pathological conditions.
In addition, the reported altered expression of some Cavb subunits (specif-
ically b1 and b2 subunits) of the high voltage activated L-type calcium
